Short interest in AN2 Therapeutics Inc (NASDAQ:ANTX) decreased during the last reporting period, falling from 379.60K to 71.42K. This put 0.37% of the company's publicly available shares short.

Short interest for AN2 Therapeutics gives investors a sense of the degree to which investors are betting on the decline of AN2 Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.77M shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.